Skip to content

Dialysis Less Frequently in the Elderly

A Randomized Controlled Study of Dialysis Less Frequently in the Elderly

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07738731
Acronym
DLITE
Enrollment
210
Registered
2026-07-31
Start date
2026-10-01
Completion date
2031-10-01
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Kidney Disease (ESKD), Hemodialysis

Keywords

Hemodialysis treatment frequency, Elderly, Quality of Life, mortality

Brief summary

Many people who have kidney failure require hemodialysis treatments to stay alive. Hemodialysis is a procedure that cleans the blood of the toxins and fluids that build up when kidneys don't work. Most patients receive hemodialysis treatment three times every week and each treatment lasts 4 hours. These patients spend 156 days per year receiving hemodialysis treatments. This is a very large time burden which has a tremendous impact on well-being and life satisfaction. Current usual approach of prescribing three hemodialysis treatments per week is not based on good studies and assumes that all people need the same number of hemodialysis treatments per week regardless of their age, values, life expectancy or other health conditions. Over time, increasingly more elderly people are needing to start hemodialysis treatments. The investigators have conducted a preliminary study that shows that patients who are 70 years of age or older can do well when only receiving only two hemodialysis treatments per week. In this preliminary study, receiving two hemodialysis treatments per week was no different than three hemodialysis treatments per week with regards to important safety measures including blood values and management of body fluid levels. The investigators now propose to carry out a much larger study in many centers across Canada that will compare two times per week hemodialysis treatments to three times per week hemodialysis treatments in elderly patients who have reached kidney failure and are beginning their hemodialysis journey. The investigators want to know if receiving hemodialysis treatments twice per week increases the number of days that a patient is able to spend at home without increasing rates of hospitalization or death compared to receiving hemodialysis treatments three times per week. The investigators also want to know if this is better for people's quality of life, safe, less expensive for the health care system and friendlier to the environment. The results of this study will help elderly patients needing to start hemodialysis treatments, medical care teams who help make decisions about how many hemodialysis treatments per week are necessary as well as kidney organizations that oversee kidney care for patients in Canada and around the world.

Interventions

OTHERTwice weekly hemodialysis

Twice weekly hemodialysis

OTHERThrice weekly hemodialysis treatment

This arm will receive three hemodialysis treatments per week

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. patients aged 70 or above 2. have developed end stage kidney disease and require hemodialysis treatment

Exclusion criteria

1. Hospitalized patients without an alternate level of care designation 2. Those with missed hemodialysis sessions due to non-adherence during the first 7 weeks of hemodialysis treatment 3. Patients already prescribed twice weekly hemodialysis 4. Patients who are medically unsuitable as per primary care team and site investigator 5. anticipated significant barriers to ascertainment of patient-reported experience measures

Design outcomes

Primary

MeasureTime frameDescription
Days Alive and Out of Hospital365 daysDays Alive and Out of Hospital is an important patient-centered goal and outcome that approximates time spent at home.

Secondary

MeasureTime frameDescription
Days Alive and Out of Hospital2 yearsDays Alive and Out of Hospital is an important patient-centered goal and outcome that approximates time spent at home
Quality-adjusted life years2 yearsImpact of treatment frequency on Quality-adjusted life years
Change in Edmonton Symptom Assessment Scale-revised Renal score from baseline to average of all follow-up assessments2 yearsImpact of treatment frequency on Quality of Life measures as assessed by the Edmonton Symptom Assessment Scale-revised Renal instrument (range 0-120 with higher scores mean a worse quality of life)
Change in Kidney Dialysis and Quality of Life-36 scores from baseline to average of all follow-up assessments2 yearsImpact of treatment frequency on quality of life as assessed by the Kidney Dialysis and Quality of Life-36 instrument (Each subscale score ranges from 0-100 where higher scores mean a better quality of life)
Clinical Frailty Scale score2 yearsAverage of all follow-up Clinical Frailty Scale score assessments controlling for baseline (range 1-9 with higher scores meaning higher frailty)
Number of urgent unscheduled hemodialysis treatment for hyperkalemia2 yearsImpact of intervention on potassium control
Number of urgent unscheduled hemodialysis treatment for volume overload2 yearsImpact of treatment frequency on volume overload
Weekly pre-hemodialysis potassium levels > 5.9 mmol/L2 yearsImpact of treatment frequency on potassium control
Change in urine volume2 yearsImpact of treatment frequency on volume of urine output
Hospitalization2 yearsImpact of treatment frequency on the number and days of hospitalization
Kidney function recovery2 yearsImpact of treatment frequency on the number of participants recovering kidney function
Elective withdrawal from hemodialysis treatment2 yearsImpact of treatment frequency on the number of participants who choose to withdraw electively from hemodialysis treatment
Cost2 yearsImpact of treatment frequency on health care cost attributed to hemodialysis treatment
Environmental costs attributed to hemodialysis treatment2 yearsImpact of treatment frequency on the environmental cost attributed to hemodialysis treatment
mortality2 yearsimpact of treatment frequency on mortality

Countries

Canada

Contacts

CONTACTChristine A White, MD
cw38@queensu.ca613-533-3134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026